	Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2- Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey. Breast Cancer (Dove Med Press) Cangür C, Bülbül B, Ye, Ucun B, Eren OÖ, Ba, Erdo, , Gökmen E, Özkan O, Araz M, Oruç A, Yilmaz C, Gül G, Yildirim S. PMID: 41868693 [PubMed - as supplied by publisher]
	Perspectives of positron emission tomography with 2-deoxy-2-fluorine-18-flu-d-glucose (18fdg-pet) in predicting the histological response of high grade epithelial ovarian cancer to neoadjuvant chemotherapy. A primary descriptive study. Am J Nucl Med Mol Imaging Lamuraglia M, Benali K, Bucau M, Nguyen T, Estevez P, Giron A, Culine S. PMID: 41868686 [PubMed - as supplied by publisher]
	Epigenetic modifications in ferroptosis regulation of breast cancer. Am J Cancer Res Lin L, Wang Y, Si W, Liu X. PMID: 41868675 [PubMed - as supplied by publisher]
	Synthesizing breast cancer ultrasound images from healthy samples using latent diffusion models. J Med Imaging (Bellingham) Wen Y, Curran KM, Wang X, Healy NA, Healy JJ. PMID: 41868563 [PubMed - as supplied by publisher]
	Breast tumor segmentation and morphological feature-based classification in ultrasound using a two-stage U-net and SVM. Front Bioeng Biotechnol Ye Y, Ye M, Wang H, Fang J, Zhang G, Yang G, Shen S, Li X. PMID: 41868544 [PubMed - as supplied by publisher]
	Regenerative High Purity Type I Collagen Scaffold for Breast Cancer Excision Repair and Reconstruction: A Prospective Multicenter Clinical Trial. Cureus Krishnappa R, Narayan N, Narasimhamurthy A, Deep SS. PMID: 41868445 [PubMed - as supplied by publisher]
	Profiles of neuropsychiatric toxicity associated with different endocrine therapies for breast cancer: a global pharmacovigilance study based on FAERS and VigiAccess. Front Pharmacol Li G, Yang M, Zhang L, Li X, Wu X, Peng F, Liu Y. PMID: 41868136 [PubMed - as supplied by publisher]
	Predictive value of ALBI score and age for developing resistance to trastuzumab in HER-2-positive breast cancer patients: prediction based on a real-world case series from a single center in China. Front Pharmacol Long J, Qin Y, Qi K, Li J. PMID: 41868130 [PubMed - as supplied by publisher]
	Psychosocial Adaptation in Breast Cancer Patients: A Mixed-MethodsÂ sequential Explanatory Study. J Multidiscip Healthc Li Q, Song J, Chen Y, Jin X. PMID: 41867428 [PubMed - as supplied by publisher]
	Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-Î² bifunctional fusion protein in recurrent cervical cancer. Hum Vaccin Immunother Mao Y, Xing N, Sun W, Bao X, Liu X, Wu R, Peng J. PMID: 41866914 [PubMed - indexed for MEDLINE]
	Ginsenoside Suppresses Triple-Negative Breast Cancer Growth and Synergizes With Programmed Cell Death Protein 1 (PD-1) Immunotherapy Through Gut Microbiota and Metabolic Regulation. Phytother Res Luo N, Li X, Hu Y, Guo L, Zhang K. PMID: 41866854 [PubMed - as supplied by publisher]
	Insights Into Vepdegestrant (ARV-471): The First-in-Class Estrogen Receptor Proteolysis-Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer. ChemMedChem Tang C, Tian B, Zhang B, Zhang Y, Ke C, Chen M, Wei M, Wang W, Deng X, Zhang Q, Wang M, Xia J, He M, Liang C, Tian L. PMID: 41866773 [PubMed - indexed for MEDLINE]
	A two-sample Mendelian Randomization study on the causal relationship between obesity and breast cancer. Clin Nutr ESPEN Chen X, Yan X, Fu Y, Zheng H, Wu Z, Ma H, Yan A, Zhao S. PMID: 41866693 [PubMed - indexed for MEDLINE]
	Risk of CNS relapse following pathological complete response to neoadjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat de Moura Leite L, de Almeida GR, Tavares MC, Cesca MG, Campos FAB, de Oliveira FA, Dornellas DMS, Saldanha EF, Guimarães PT, de Arruda DDS, de Held MFSD, Viana RL, Moura FGR, Loose SK, Silva SF, Pirolli R, Fogassa CAZ, Mattos BRS, Sanches SM, de Lima VCC. PMID: 41866643 [PubMed - indexed for MEDLINE]
	A cancer neuroscience-related gene model for prognosis prediction and immunotherapy response evaluation in breast cancer. Discov Oncol Wei Y, Li J, Li M, Qiu C. PMID: 41866616 [PubMed - as supplied by publisher]
	Iï»¿s Neoadjuvant Chemotherapy Justified When Triple-Negative Breast Cancer or HER2-Positive Breast Cancer Presents as â‰¥1 cm of Only Calcifications or as a Subcentimeter Mass with Surrounding Calcificationï»¿s? Ann Surg Oncol Meneveau MO, Sevilimedu V, Le T, Eskreis-Winkler S, Morrow M. PMID: 41866571 [PubMed - as supplied by publisher]
	A clinical review of cervical cancer. Nursing Pullen RL Jr, Ritchie S. PMID: 41866531 [PubMed - indexed for MEDLINE]
	Insulin resistance as a modifiable contributor to breast cancer: mechanisms, biomarkers, and therapeutic implications. Discov Oncol Marouf SP, Meskar Z, Rezaei N. PMID: 41866451 [PubMed - as supplied by publisher]
	A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast Cancer. Psychooncology Wallace R, Alexander M, Day D, Diggens J, Ftanou M, Aedo-Lopez V, Bei B, Blum R, Boyle F, Do TT, Francis PA, Garland SN, Maccora J, Sharma S, Stafford L, White M, Mortimer D, Wiley JF. PMID: 41866301 [PubMed - indexed for MEDLINE]
	Listening to Australians with ovarian cancer: a cross-sectional survey investigating clinical trials awareness, information access and participation. Support Care Cancer Williams N, Lee YC, Russell H, Andrews J, Chen WS, Bradhurst B. PMID: 41865188 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 326257

Page 1 of 16313



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy